13F Pro

SEC Form 4 reporting owner

Abernethy Matt

Abernethy Matt has filed 17 Form 4 transactions reported between January 31, 2026 and September 14, 2026, as Chief Financial Officer of NEUROCRINE BIOSCIENCES INC and a reporting owner of FATE THERAPEUTICS INC.

Name as filed: ABERNETHY MATT

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$363K
1 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 14, 2026
transaction date

Roles and reported holdings

  • NBIXNEUROCRINE BIOSCIENCES INC
    Jan 31, 2026 – Sep 14, 2026

    Chief Financial Officer

    Held directly42,808 sh as of Sep 14, 2026 · Form 4

    24 months: $363K sold

  • FATEFATE THERAPEUTICS INC
    Jun 12, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 14, 2026NBIXChief Financial OfficerOpen-market saleCode S · direct2,311$363K@ $157.20Form 4
Sep 11, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct2,709$423K@ $156.22Form 4
Sep 11, 2026NBIXChief Financial OfficerGrant or awardCode A · direct5,020—Form 4
Jun 12, 2026FATEGrant or awardCode A · direct87,900—Form 4
Mar 4, 2026NBIXChief Financial OfficerGiftCode G · direct2,249—Form 4
Feb 13, 2026NBIXChief Financial OfficerGrant or awardCode A · direct7,735—Form 4
Feb 13, 2026NBIXChief Financial OfficerGrant or awardCode A · direct44,095—Form 4
Feb 13, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct5,378$668K@ $124.12Form 4
Feb 13, 2026NBIXChief Financial OfficerGrant or awardCode A · direct9,968—Form 4
Feb 13, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,385$172K@ $124.12Form 4
Feb 13, 2026NBIXChief Financial OfficerOption exerciseCode M · direct2,566—Form 4
Feb 13, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,210$150K@ $124.12Form 4
Feb 13, 2026NBIXChief Financial OfficerOption exerciseCode M · direct2,241—Form 4
Feb 12, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,151$142K@ $123.10Form 4
Feb 12, 2026NBIXChief Financial OfficerOption exerciseCode M · direct2,133—Form 4
Jan 31, 2026NBIXChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,368$186K@ $136.06Form 4
Jan 31, 2026NBIXChief Financial OfficerOption exerciseCode M · direct2,437—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.